Methods of increasing cerebral blood flow
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsDaria Mochly-Rosen, Rachel Bright
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsDaria Mochly-Rosen, Rachel Bright
Estimating the term…
Methods of increasing blood flow in a mammalian brain blood vessel characterized by, or otherwise experiencing, decreased blood flow due to an ischemic or other hypoxic event, vasoconstriction or vasospasm following hemorrhagic stroke; due to chronic high blood pressure; and/or due to idiopathic causes are provided. The method for increasing blood flow in such a mammalian brain blood vessel includes administering to a patient in need thereof a therapeutically effective amount of an inhibitor of δ protein kinase C. In certain embodiments, the inhibitor can be chronically administered without causing desensitization of the patient to the inhibitor. Kits for increasing blood flow in a mammalian brain blood vessel characterized by, or otherwise experiencing, decreased blood flow due to an ischemic or other hypoxic event, vasoconstriction or vasospasm following hemorrhagic stroke; due to chronic high blood pressure; and/or due to idiopathic causes are provided.
A method of treating an individual with a disease that causes decreased cerebral blood flow or an idiopathic cause that causes decreased cerebral blood flow, comprising administering a therapeutically effective amount of a peptide inhibitor of δ protein kinase C (δPKC), whereby said administering increases blood flow in a brain blood vessel.
A kit for increasing blood flow in a mammalian brain blood vessel in an individual with a disease that causes decreased cerebral blood flow or an idiopathic cause that causes decreased blood flow, comprising a peptide inhibitor of δPKC and instructions for using said inhibitor to increase blood flow in said blood vessel.
Dependencies are inferred from the claim text.